JNJ241220P160000
- 17.10
- 0.000.00%
Johnson & Johnson Newsroom
Bernstein Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $161
Morgan Stanley Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $175
RBC Capital Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $181
Bank of America resumes coverage of Johnson & Johnson with a Target Price of $166.
Johnson & Johnson Analyst Ratings
Citi Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Cuts Target Price to $175
Johnson & Johnson Analyst Ratings
B of A Securities Reinstates Neutral on Johnson & Johnson, Announces $166 Price Target
Wells Fargo Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $166
Morgan Stanley Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $175
Johnson & Johnson Initiated at Outperform by Wolfe Research
Johnson & Johnson Analyst Ratings
Wolfe Research Upgrades Johnson & Johnson(JNJ.US) to Buy Rating, Raises Target Price to $190
Johnson & Johnson Analyst Ratings
Guggenheim Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Cuts Target Price to $162
Guggenheim Adjusts Johnson & Johnson's Price Target to $162 From $156, Keeps Neutral Rating
Daiwa Securities Adjusts Price Target on Johnson & Johnson to $170 From $150, Maintains Neutral Rating
Daiwa raised johnson & johnson's target price to $175.
A Quick Look at Today's Ratings for Johnson & Johnson(JNJ.US), With a Forecast Between $166 to $185
Goldman Sachs Lowers Price Target on Johnson & Johnson to $159 From $162